Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database

A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay

(2018) Sébastien Viel et al.   Frontiers in Immunology

Good Signal Detection Practices: Evidence from IMI PROTECT

(2016) Antoni F. Z. Wisniewski et al.   DRUG SAFETY

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank

(2014) Ola Caster et al.   DRUG SAFETY

Severe Guillain–Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review

(2013) Bonifacio Alvarez-Lario et al.   CLINICAL RHEUMATOLOGY

Comparison of Three Methods (An Updated Logistic Probabilistic Method, the Naranjo and Liverpool Algorithms) for the Evaluation of Routine Pharmacovigilance Case Reports Using Consensual Expert Judgement as Reference

(2013) Hélène Théophile et al.   DRUG SAFETY

The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist

(2013) Nicholas Moore   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

DPP4 inhibitor-induced polyarthritis: a report of three cases

(2013) Etienne Crickx et al.   RHEUMATOLOGY INTERNATIONAL

Œdème papillaire sous clozapine

(2012) David Koenig et al.   REVUE NEUROLOGIQUE

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

(2011) G Niklas Norén et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

False Discovery Rate Estimation for Frequentist Pharmacovigilance Signal Detection Methods

(2009) I. Ahmed et al.   BIOMETRICS

Methods for Causality Assessment of Adverse Drug Reactions

(2009) Taofikat B Agbabiaka et al.   DRUG SAFETY

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting

(2009) Ismaïl Ahmed et al.   STATISTICS IN MEDICINE